Literature DB >> 23592127

Significance of fractional exhaled nitric oxide combined with serum procalcitonin and C-reactive protein in evaluation of elderly asthma.

Ji-Zhen Wu1, Li-Jun Ma1, Li-Min Zhao2, Xiao-Yu Zhang1, Xian-Liang Chen1, Hong-Yan Kuang1.   

Abstract

Bronchial asthma is a common chronic airway inflammatory disease. Asthma is associated with high mortality, especially in the elderly patients. Repeated exacerbations cause disease progression. Therefore, identifying the onset of acute elderly asthma as soon as possible and giving the effective treatment is crucial to improve the prognosis. This study was to investigate the significance of fractional exhaled nitric oxide (FeNO) combined with serum procalcitonin (PCT) and C-reactive protein (CRP) in the evaluation of elderly asthma. A total of 120 elderly patients with an acute attack of asthma from July, 2010 to May, 2012 were studied. On presentation, FeNO, serum PCT and CRP concentrations were measured and sputum culture was also performed. The elderly patients were re-evaluated when they had returned to their stable clinical state. The elderly patients were classified into two groups: positive bacterial culture group (A) and negative bacterial culture group (B). The results showed that: (1) In patients with an acute exacerbation of asthma, 48 (40%) patients had positive sputum bacterial culture and 72 (60%) had negative sputum bacterial culture. (2) The levels of FeNO in patients with acute exacerbation of asthma were significantly higher than in those with no acute exacerbation state (63.8±24.6 vs. 19±6.5 ppb, P<0.05). There was no significant difference in FeNO between group A and group B (P>0.05). (3) The levels of PCT and CRP in group A patients with an acute exacerbation of asthma were significantly higher (P<0.05) than in group B (for PCT: 27.46±9.32 vs. 7.85±3.52 ng/mL; for CRP: 51.25±11.46 vs. 17.11±5.87 mg/L, respectively). When they had returned to stable clinical state, the levels of PCT and CRP in group A were decreased significantly (P<0.05), and those in group B had no significant change (P>0.05) when compared with the exacerbation group. There were no significant differences in the levels of PCT and CRP between the two groups in non-acute exacerbation state (P>0.05). These results suggest that the increase in FeNO indicates the acute exacerbation of asthma, and the elevation of serum PCT and CRP levels may be associated with bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592127     DOI: 10.1007/s11596-013-1094-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  Markers for step-down of inhaled corticosteroid therapy in adult asthmatics.

Authors:  Naomi Tsurikisawa; Chiyako Oshikata; Takahiro Tsuburai; Chihiro Mitsui; Hidenori Tanimoto; Kentaro Takahashi; Kiyoshi Sekiya; Takuya Nakazawa; Kenji Minoguchi; Mamoru Otomo; Yuji Maeda; Hiroshi Saito; Kazuo Akiyama
Journal:  Allergol Int       Date:  2012-09       Impact factor: 5.836

Review 2.  The value of FeNO measurement in asthma management: the motion against FeNO to help manage childhood asthma--reality bites.

Authors:  Peter J Franklin; Stephen M Stick
Journal:  Paediatr Respir Rev       Date:  2008-05-15       Impact factor: 2.726

3.  Seasonal variation and environmental predictors of exhaled nitric oxide in children with asthma.

Authors:  Adam J Spanier; Richard W Hornung; Robert S Kahn; Michelle B Lierl; Bruce P Lanphear
Journal:  Pediatr Pulmonol       Date:  2008-06

4.  Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management.

Authors:  Richard S Hewitt; Catherine M Modrich; Jan O Cowan; G Peter Herbison; D Robin Taylor
Journal:  Prim Care Respir J       Date:  2009-12

5.  Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.

Authors:  Daiana Stolz; Mirjam Christ-Crain; Roland Bingisser; Jörg Leuppi; David Miedinger; Christian Müller; Peter Huber; Beat Müller; Michael Tamm
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

6.  The link between exhaled NO and bronchomotor tone depends on the dose of inhaled steroid in asthma.

Authors:  Bruno Mahut; Ludovic Trinquart; Plamen Bokov; Claudine Peiffer; Christophe Delclaux
Journal:  Respir Med       Date:  2010-02-26       Impact factor: 3.415

7.  [Procalcitonin as monocytic marker for early diagnosis in septic abortion].

Authors:  S Russwurm; M Wiederhold; M Oberhoffer; I Stonans; G Peiker; K Reinhart
Journal:  Z Geburtshilfe Neonatol       Date:  2000 Jan-Feb       Impact factor: 0.685

8.  Is FENO50 useful diagnostic tool in suspected asthma?

Authors:  F N Schleich; R Asandei; M Manise; J Sele; L Seidel; R Louis
Journal:  Int J Clin Pract       Date:  2012-02       Impact factor: 2.503

9.  Is exhaled nitric oxide a useful adjunctive test for assessing asthma?

Authors:  Jonathan A Bernstein; Ben Davis; María J Alvarez-Puebla; Douglas Nguyen; Linda Levin; Jose M Olaguibel
Journal:  J Asthma       Date:  2009-11       Impact factor: 2.515

10.  Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.

Authors:  William J Anderson; Philip M Short; Peter A Williamson; Brian J Lipworth
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.